• Remdesivir

    Remdesivir

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Remdesivir Antiviruls(Ebola, Covid-19) Gilead  

     

  • Paxlovid

    Paxlovid

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Paxlovid Covid-19  Pfizer  

     

  • Pomalidomide

    Pomalidomide

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Pomalidomide Oncology drug  Celgene   

     

  • Nirmatrelvir

    Nirmatrelvir

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Nirmatrelvir 3C-Like Protease (3CLPRO) Inhibitor And SARS-Cov-2 Mpro Inhibitor    

     

  • Eltrombopag

    Eltrombopag

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Eltrombopag ITP & Aplastic anemia  Novartis & GSK  May. 20, 2023
  • Ruxolitinib

    Ruxolitinib

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Ruxolitinib Myelofibrosis Novartis Jul. 6, 2024
  • Crisaborole

    Crisaborole

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Crisaborole Atopic Dermatitis and Eczema Pfizer Jun. 11, 2026 
  • Relugolix

    Relugolix

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Relugolix Prostatic cancer Takeda and ASKA Jan. 24, 2024
  • Vericiguat

    Vericiguat

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Vericiguat Heart failure Bayer and MSD May. 24, 2031
  • Abrocitinib

    Abrocitinib

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Abrocitinib Atopic Dermatitis Pfizer Feb.11, 2034
  • Rimegepant

    Rimegepant

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Rimegepant Migraine headache Biohaven Feb. 22, 2031

     

  • Elagolix 834153-87-6

    Elagolix 834153-87-6

    API’s Name Indication Specification US DMF EU DMF CEP
    Elagolix CAS: 834153-87-6 Endometriosis In-House      
1234 Next > >> Page 1 / 4